A new study, published in the Annals of Internal Medicine, says that if gay and bi men with HIV undergo routine screening for ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

At least 120 people in Quezon province have died due to human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) from 1987 to February 2025, according to ...

Greg Kesterman, Hamilton County Public Health commissioner, advised that people who are in the first half of their pregnancy ...

Furthermore, the rash will usually last two weeks to nearly a month. Making matters worse, the HIV rash can usually appear on our face. It’s one thing to have a face full of pimples but entirely ...

LOS ANGELES — HIV infections in LA County have been steadily declining for years, from nearly 7,000 per year in the 1990s to 1,400 in 2024, according to the Los Angeles County Department of Public ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at-risk adults and adolescents, Gilead Sciences announced on Wednesday ...

The U.S. Food and Drug Administration (FDA) on Wednesday (June 18) approved Gilead Sciences, opens new tab lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and ...